Towards personalized medicine for cystic fibrosis patients with rare mutations

J Physiol. 2024 Jan;602(2):257-258. doi: 10.1113/JP286135. Epub 2024 Jan 3.

Author

László Csanády^{1

2

3}

Affiliations

¹ Department of Biochemistry, Semmelweis University, Budapest, Hungary.
² Hungarian Centre of Excellence for Molecular Medicine - Semmelweis University Molecular Channelopathies Research Group, Budapest, Hungary.
³ Hungarian Research Network - Semmelweis University Ion Channel Research Group, Budapest, Hungary.

PMID: 38167788
DOI: 10.1113/JP286135

No abstract available

Keywords: cystic fibrosis; personalized medicine; rare mutation.

MeSH terms

Cystic Fibrosis Transmembrane Conductance Regulator / genetics
Cystic Fibrosis* / genetics
Cystic Fibrosis* / therapy
Humans
Mutation
Precision Medicine

Substances

Cystic Fibrosis Transmembrane Conductance Regulator

Grants and funding